OmniActive launches new plant-extract weight management product
Dietary supplement ingredient company OmniActive Health Technologies announced that it will launch OmniLean, made out of the extract of the woody Salacia plant, at Engredea 2016 in Anaheim, Calif.
“OmniLean is unique because it is specifically designed to address multiple facets of metabolic health – carbohydrate and lipid metabolism and healthy weight management,” Lynda Doyle, VP of Global marketing at OmniActive Health Technologies, told NutraIngredients-USA.
Metabolic synergizers
Doyle said that OmniLean is part of a new category that the company has termed “metabolic synergizers,” which means products that aid with a more holistic approach to weight management.
“As consumers are increasingly looking for a simple and comprehensive solution to support their health goals it’s not just about losing inches anymore but being healthy,” she said. “What [we have] termed as ‘metabolic synergizers’ are ingredients that support multiple health outcomes associated with heart health and healthy carbohydrate and lipid metabolism as a part of an overall approach to support health that includes weight management.”
“To truly be a metabolic synergizer, OmniLean was designed to meet specific quantification of both bioactives [and] bioactivity,” she added. “OmniLean is our flagship ingredient in this category supporting multiple facets of weight management in one specifically designed extract.”
Pursuing further validation
As of now, the new product has only gone through OmniActive’s internal verification program, called PlantActive, to “ensure that every batch of OmniLean provides both beneficial levels of active compounds and biologic activity to support healthy carbohydrate and lipid metabolism for weight management,” Doyle explained.
She added that the company is currently pursuing clinical programs to further validate the benefits of OmniLean beyond the safety, preclinical, and efficacy work the company did internally.
In terms of usage, OmniActive’s testing found that only 300 – 500 mg of OmniLean is needed, “compared [to] the general science on Salacia that used as much as 2,000 mg,” Doyle said. “Smaller doses and the fact that it has little impact on taste mean greater formulation flexibility in capsules, tablets, and powder formulas.”
